TABLE 1

Patient Characteristics

Patient no.	Age (y)	Type of MF	Grade of MF	Previous treatment	Hemoglobulin (g/dL)	Leukocytes (10⁹/L)	Thrombocytes (10⁹/L)
1	50	post-PV	2	IFN	14.6	8.60	285
2	51	PMF	1	IFN	15.1	4.60	205
3	52	post-ET	3	IFN	10.6	4.94	262
4	59	post-PV	1	IFN	11.8	3.79	118
5	73	post-ET	1	UNT	8.9	6.20	121
6	53	PMF	3	RUXO	8.9	15.97	300
7	51	PMF	3	RUXO	11.7	5.41	78
8	70	PMF	2	UNT	7.4	22.54	130
9	75	post-PV	1	UNT	14.9	8.193	146
10	49	PMF	2	UNT	13.7	8.73	193
11	69	PMF	1	UNT	13.2	5.39	246
12	70	post-ET	2	RUXO	9.1	14.95	352
13	69	PMF	3	RUXO	7.9	8.12	68
14	65	post-ET	2	UNT	11.2	3.90	180
15	71	PMF	2	UNT	11.3	14.38	215

MF = myelofibrosis; post-PV = postpolycythemia vera; IFN = interferon; PMF = primary myelofibrosis; post-ET = postessential thrombocythemia; UNT = untreated; RUXO = ruxolitinib.